NYMC Faculty Publications
Document Type
Response or Comment
Publication Date
9-1-2017
Department
Epidemiology and Community Health
Recommended Citation
Cheng, L., Nelson, B., Mehta, M., Shi, Q., Gomez-Simmonds, A., & Uhlemann, A. (2017). Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy Against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?". Antimicrobial Agents and Chemotherapy, 61 (9), e01163-17. https://doi.org/10.1128/AAC.01163-17
